Abstract

L-arginine modified graphene oxide (GO-Arg) was introduced as a new heterogeneous biocatalyst for synthesis of benzo[b]pyran and pyrano[3,2‑c]chromene derivatives. First GO was synthesized and then, Arg was covalently bonded on its surface. The new catalyst was analyzed using spectroscopic techniques such as Fourier transform infrared (FT-IR), X-ray diffraction (XRD), Field emission scanning electron microscopy (SEM), X-ray photoelectron spectroscopy (XPS), Energy-dispersive X-ray spectroscopy (EDS) and Raman. XRD analysis results showed that, Arg was located between the graphene oxide layers. Comparison of the bond intensity ratio of the D and G (ID/IG) in GO and GO-Arg confirmed the presence of Arg via covalent bond on the GO surface. XPS analysis also confirmed the successful modification through the presence of CN bonds in the structure. Moreover, changes in morphology of the samples were observed using SEM analyze, respectively. Evaluation of the performance of the catalyst in the synthesis of benzo[b]pyran and pyrano[3,2‑c]chromene derivatives showed presentable results. Using of amino acid as an available organocatalyst, its stabilization by a simple method on graphene oxide, reusing the catalyst up to 5 times, and introducing a highly pure product are positive points of this work.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.